BioSpace News Archive

Press Releases

Last Patient has Completed AlzeCure’s Phase Ib Clinical Study with NeuroRestore ACD856

April 20, 2026
·
6 min read
Press Releases

Fapon Biopharma Presents at AACR Annual Meeting 2026, Showcasing Core Technology Platforms and Advancing Pipeline

April 20, 2026
·
3 min read
Press Releases

AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026

April 20, 2026
·
2 min read
Press Releases

Senzime Wins Expanded Contract Within Leading Southeastern US Hospital System

April 20, 2026
·
2 min read
Press Releases

Labbit Goes All-In on LIMS Platform, Retires Semaphore Solutions Brand

April 20, 2026
·
2 min read
Press Releases

Novo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease

April 20, 2026
·
6 min read
Press Releases

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026

April 20, 2026
·
16 min read
Press Releases

Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026

April 20, 2026
·
7 min read
Press Releases

Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema

April 20, 2026
·
9 min read
Press Releases

SynSmart and Amporin Announce Collaboration to Develop Breakthrough Small Molecule Therapeutics for Degenerative Diseases

April 20, 2026
·
2 min read